GlassScriptPhysician profile
Tyrone A Mayorga
NPI 1346731247
$5,163.20
in general payments reported to CMS, 2019-2025
10 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.94 · 2022: $2,891 · 2023: $560 · 2024: $556 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $2,791.72 | 2021-2025 | |
| Stryker Corporation | $1,536.14 | 2022-2025 | Citrefix, Prostep Mica, Everest Spinal System |
| Medtronic, INC. | $475.35 | 2022-2025 | Anatomic Peek Ptc Cervical Fusion System, Inceptiv |
| Smith+Nephew, INC. | $150.70 | 2021-2024 | Footprint, Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Treace Medical Concepts, INC. | $64.05 | 2023-2024 | |
| Depuy Synthes Sales INC. | $45.46 | 2024-2025 | Dynatape, Truespan Orthocord, Milagro |
| Zimvie INC. | $43.05 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $28.34 | 2025 | Nuzyra |
| Vertex Pharmaceuticals Incorporated | $16.56 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $11.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyrone Mayorga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.